icon-folder.gif   Conference Reports for NATAP  
 
  ID Week
Oct 21 - October 25
Back grey_arrow_rt.gif
 
 
 
Efficacy and Safety of Doravirine in Treatment-Na´ve Adults ≥50 Years Old With HIV-1
 
 
  IDWeek 2020 Oct 21-25 virtual
Reported by Jules Levin
 
Anthony M. Mills1; Elizabeth A. Martin2; Chih-Chin Liu2;Martine Drolet2; Peter Sklar2 1Men's Health Foundation, Los Angeles, CA, USA;2Merck & Co., Inc., Kenilworth, NJ, USA

1026201

1026202

1026203

1026204

1026205

1026206

1026207

1026208